(19)
(11) EP 1 644 338 A1

(12)

(43) Date of publication:
12.04.2006 Bulletin 2006/15

(21) Application number: 04723991.8

(22) Date of filing: 29.03.2004
(51) International Patent Classification (IPC): 
C07D 239/40(1985.01)
C07D 403/12(1990.01)
C07D 405/04(1990.01)
A61K 31/505(1985.01)
A61P 37/00(2000.01)
 C07D 239/42(1985.01)
C07D 401/06(1990.01)
C07D 401/04(1990.01)
A61P 35/00(2000.01)
(86) International application number:
PCT/EP2004/003296
(87) International publication number:
WO 2004/087679 (14.10.2004 Gazette 2004/42)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 01.04.2003 EP 03405219
03.09.2003 EP 03405642

(71) Applicant: Aponetics AG
4108 Witterswil (CH)

(72) Inventors:
  • OBRECHT, Daniel
    CH-4112 Bättwil (CH)
  • ERMERT, Philipp
    CH-4123 Allschwil (CH)
  • LUTHER, Anatol
    D-79639 Grenzach-Wyhlen (DE)
  • EBERLE, Martin
    CH-4103 Bottmingen (CH)
  • BACHMANN, Felix
    CH-4052 Basel (CH)

(74) Representative: Eisenführ, Speiser & Partner 
Patentanwälte Rechtsanwälte Postfach 10 60 78
28060 Bremen
28060 Bremen (DE)

   


(54) 2, 4, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES